RHUMBLINE ADVISERS - BIOSCRIP INC ownership

BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 100 filers reported holding BIOSCRIP INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of BIOSCRIP INC
ValueSharesWeighting
Q1 2019$361,000
-44.7%
180,506
-1.3%
0.00%0.0%
Q4 2018$653,000
+65.7%
182,883
+43.8%
0.00%0.0%
Q3 2018$394,000
+5.9%
127,209
+0.3%
0.00%0.0%
Q2 2018$372,000
+39.3%
126,878
+16.9%
0.00%0.0%
Q1 2018$267,000
-17.6%
108,506
-2.5%
0.00%0.0%
Q4 2017$324,000
-10.5%
111,291
-15.4%
0.00%0.0%
Q3 2017$362,000
+2.5%
131,557
+1.1%
0.00%0.0%
Q2 2017$353,000
+73.9%
130,122
+9.2%
0.00%
Q1 2017$203,000
+66.4%
119,137
+1.4%
0.00%
Q4 2016$122,000
-64.3%
117,537
-0.8%
0.00%
-100.0%
Q3 2016$342,000
+72.7%
118,498
+52.7%
0.00%0.0%
Q2 2016$198,000
-12.4%
77,623
-26.6%
0.00%0.0%
Q1 2016$226,000
+34.5%
105,769
+10.0%
0.00%0.0%
Q4 2015$168,000
-2.9%
96,144
+3.9%
0.00%0.0%
Q3 2015$173,000
-45.1%
92,574
+6.5%
0.00%0.0%
Q2 2015$315,000
-24.1%
86,897
-7.1%
0.00%0.0%
Q1 2015$415,000
-33.3%
93,567
+5.2%
0.00%
-50.0%
Q4 2014$622,000
+11.3%
88,967
+10.0%
0.00%0.0%
Q3 2014$559,000
-17.2%
80,867
-0.1%
0.00%0.0%
Q2 2014$675,000
+44.2%
80,917
+20.7%
0.00%
+100.0%
Q1 2014$468,000
-9.1%
67,019
-3.7%
0.00%
-50.0%
Q4 2013$515,000
-24.8%
69,569
-10.8%
0.00%0.0%
Q3 2013$685,000
-46.7%
77,969
+0.0%
0.00%
-50.0%
Q2 2013$1,286,00077,9540.00%
Other shareholders
BIOSCRIP INC shareholders Q2 2019
NameSharesValueWeighting ↓
Coliseum Capital Management, LLC 5,622,410$5,847,0002.64%
NORTH TIDE CAPITAL, LLC 8,500,000$8,840,0001.51%
WYNNEFIELD CAPITAL INC 3,700,000$3,848,0001.39%
Alta Fundamental Advisers LLC 2,330,774$2,424,0001.20%
ARDSLEY ADVISORY PARTNERS LP 6,350,000$6,604,0001.09%
Camber Capital Management LP 10,180,000$10,587,0000.55%
PERKINS CAPITAL MANAGEMENT INC 298,000$310,0000.34%
Hawk Ridge Capital Management 340,429$354,0000.18%
Eidelman Virant Capital 220,000$228,0000.13%
ROANOKE ASSET MANAGEMENT CORP/ NY 227,280$236,0000.11%
View complete list of BIOSCRIP INC shareholders